跳至主要内容
临床试验/ACTRN12616000175471
ACTRN12616000175471已完成未知

sing wearable technology activity monitors to increase physical activity and decrease sitting time amongst breast cancer survivors: the ACTIVity And TEchnology (ACTIVATE) Trial

Cancer Council Victoria0 个研究点目标入组 92 人开始时间: 2016年2月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
Female

入选标准

  • Post-menopausal breast cancer survivors, diagnosed with stage I-III breast cancer, who have completed primary treatment (surgery, chemotherapy, radiation therapy – ongoing hormone therapy is acceptable). Other eligibility criteria include: engaging in more than six hours of sitting each day; less than 75 minutes of moderate-vigorous physical activity per week; able to speak/write fluently in English; having daily access to a smart phone, mobile device or personal computer.

排除标准

  • Pre-menopausal women. Women diagnosed with breast cancer still undergoing primary treatment. Those engaging in less than six hours of sitting each day; more than 75 minutes of moderate-vigorous physical activity per week.

研究者

相似试验

sing wearable technology activity monitors to... | 临床试验